XFOR
X4 Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$3.69
-0.19 ▼ -4.90%
🌙 3월 13일 6:11 PM ET (한국 3/14 07:11)
$3.64
-0.05 ▼ -1.36%
| Index | - | P/E | - | EPS (ttm) | -10.01 | Insider Own | 22.88% | Shs Outstand | 0.09B | Perf Week | -1.86% |
| Market Cap | 0.32B | Forward P/E | - | EPS next Y | 52.46% | Insider Trans | 0.43% | Shs Float | 0.07B | Perf Month | 7.58% |
| Enterprise Value | 0.28B | PEG | - | EPS next Q | -0.27 | Inst Own | 83.45% | Short Float | 5.13% | Perf Quarter | -5.14% |
| Income | -0.10B | P/S | 9.49 | EPS this Y | 63.38% | Inst Trans | 82.16% | Short Ratio | 5.81 | Perf Half Y | 11.82% |
| Sales | 0.03B | P/B | 1.51 | EPS next 5Y | 45.45% | ROA | -55.66% | Short Interest | 3.46M | Perf YTD | -7.75% |
| Book/sh | 2.45 | P/C | 2.64 | EPS past 3/5Y | 63.98% 47.41% | ROE | -156.87% | 52W High | -64.84% ($10.49) | Perf Year | -61.15% |
| Cash/sh | 1.4 | P/FCF | - | Sales past 3/5Y | - | ROIC | -69.02% | 52W Low | 173.33% ($1.35) | Perf 3Y | -86.49% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -294.29% | Gross Margin | 81.58% | Volatility(W/M) | 11.04% 8.24% | Perf 5Y | -98.71% |
| Dividend TTM | - | EV/Sales | 8.17 | Sales Y/Y TTM | 2925.73% | Oper. Margin | -291.06% | ATR (14) | 0.3 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 5.48 | EPS Q/Q | 87.43% | Profit Margin | -279.86% | RSI (14) | 49.97 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 5.65 | Sales Q/Q | 215.18% | SMA20 | 4.18% ($3.54) | Beta | 0.4 | Target Price | $10 |
| Payout | - | Debt/Eq | 1.26 | Earnings | 11000000 | SMA50 | 0.4% ($3.68) | Rel Volume | 0.36 | Prev Close | $3.88 |
| Employees | 143 | LT Debt/Eq | 1.24 | EPS/Sales Surpr. | -36.63% -7.22% | SMA200 | 13.96% ($3.24) | Avg Volume(3M) | 0.60M | Price | $3.69 |
| IPO | 2017/11/16 | Option/Short | No/Yes | Trades | 2059 | Volume | 216,950 | Change | -4.9% |
뉴스 로딩 중...